Overview

Capecitabine as NeoAdjuvant Therapy in Locally Advanced Breast Cancer

Status:
Terminated
Trial end date:
2013-03-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess the safety and effectiveness of capecitabine before surgery. The study will also help gain more information about the effects of the capecitabine on physical and emotional well-being and how well the participants on capecitabine follow the study drug plan.
Phase:
Phase 2
Details
Lead Sponsor:
University of Chicago
Collaborators:
Breast Cancer Research Foundation
Roche Pharma AG
Treatments:
Capecitabine